Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Sekisui Diagnostics

Download Mobile App




Reinforced Stent Treats Venous Outflow Obstruction

By HospiMedica International staff writers
Posted on 17 Dec 2014
A new venous stent system conforms to the unique anatomy and pathophysiology of the venous system, including crush resistance, vessel coverage, and flexibility.

The Vici Venous Stent System is intended for use in veins of the lower extremities and pelvis, including the iliac and common femoral veins, and in patients who exhibit symptomatic venous outflow obstruction. More...
The system comprises two components: the stent implant itself and the disposable delivery system. The stent is a laser cut, self-expanding tube made of a nickel titanium alloy (nitinol) with closed-cell segments and proprietary bridges and braces, designed to provide strength and flexibility in the venous anatomy.

Since venous disease requires a high degree of crush resistance, the radial stiffness of the venous stent is maximized to resist compression and improve vessel patency. The delivery system is a coaxial, over-the-wire (OTW) design with an exterior shaft to protect and constrain the stent prior to deployment. It is compatible with a 9F sheath introducer, and can be delivered via either a jugular or femoral vein approach. The Vici Venous Stent System is a product of Veniti (St. Louis, MO, USA), and has received the European Community CE marking of approval.

“The Veniti Vici venous stent appears to have the radial strength and vein coverage to provide optimal results in patients with symptomatic outflow obstruction of the lower extremities,” said Stephen Black, MD, a consultant vascular surgeon at St. George’s Vascular Institute (London, United Kingdom), who implanted Veniti Vici stents in five patients with symptomatic venous outflow obstruction of the lower extremities. “Having a stent that was designed from its inception for use in veins makes this an important addition to my treatment options.”

Symptomatic venous outflow obstruction of the iliofemoral vein is a common complication of deep vein thrombosis (DVT) and May-Thurner syndrome (MTS), which is caused when the left iliac vein is compressed by the right iliac artery, which increases the risk of DVT in the left extremity. Until the advent of stents, patients did not have many options, and were treated with compression stockings, by elevating the leg, or with different pharmaceutical agents.

Related Links:

Veniti



Gold Member
Handheld Blood Glucose Analyzer
STAT-Site
Radiology Monitor
MDNC-6121 Barco Nio Color 5.8MP
Syringe Pump
SP50 Series
Wound Irrigation Solution
Prontosan®
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Artificial Intelligence

view channel
Image: Clinical LLM Performance Improves by >300% When Provided with High-Quality Real-World Evidence in New Precision Medicine Benchmark (Photo courtesy of Atropos Health)

New Benchmark Highlights Evidence Gaps in AI Responses to Clinical Questions

Many clinical decisions still rely on limited evidence, while most artificial intelligence benchmarks overlook the patient context that shapes real-world care. General large language models can also struggle... Read more

Critical Care

view channel
Image: Lead study author Ramy Ghanim (left) and co-author Joy Jackson test an small implantable device alongside Assistant Professor Alex Abramson. In a new Science paper, they describe a networking system that connects therapeutic implants and wearable devices by using the body’s natural conductivity to send tiny signals. (Photo courtest of Georgia Tech)

Bioelectronic Network Enables Devices to Communicate Through Body Tissue and Coordinate Therapy

Wearable sensors and implanted therapeutic devices can be difficult to coordinate when signals must pass through the body. Conventional wireless signals do not travel well through tissue, while the antennas... Read more

Point of Care

view channel
Image Credit: 123RF

Continuous Glucose Monitoring Identifies Cardiometabolic Risk in Adults Without Diabetes

Dysglycemia—abnormal blood glucose regulation—can fluctuate throughout the day and often escape conventional screening. Clinicians typically rely on fasting plasma glucose and hemoglobin A1c, which offer... Read more

Business

view channel
Image: LigaSure RAS Maryland, designed for the Valleylab FT10 platform on Hugo RAS, seals and cuts vessels, tissue, and lymphatics up to 7 mm in diameter (Photo courtesy of Medtronic)

Medtronic Receives FDA Clearance for Vessel-Sealing Instrument for Robotic Surgery

As robotic-assisted surgery expands across U.S. hospitals, teams increasingly seek energy instruments with the familiarity and performance of tools used in open and laparoscopic procedures.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.